Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01218828 · ClinicalTrials.gov registry record · Phase 3
Prevention of Contrast Renal Injury With Different Hydration Strategies
A Phase 3 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 396
- Enrollment target
NCT01218828: Completed Phase 3 study, sponsored by Kaiser Permanente.
NCT01218828 is a Phase 3 study that has completed, run by Kaiser Permanente. The registered enrollment target is 396 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01218828, a Phase 3 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 396 participants
- Enrollment target
Study Summary
Using a randomized controlled trial design, two hydration protocols for the prevention of contrast medium-induced nephropathy will be tested.
Interventions
- OTHER LVEDP -Based hydration strategy
- OTHER Standard hydration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
What the finished NCT01218828 record still lists
NCT01218828 is an interventional study that assigns participants to a tested intervention. The registered 396 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which LVEDP -Based hydration strategy is the first listed.
NCT01218828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01218828 about?
NCT01218828 is a clinical study titled "Prevention of Contrast Renal Injury With Different Hydration Strategies". Using a randomized controlled trial design, two hydration protocols for the prevention of contrast medium-induced nephropathy will be tested.
What is the current status of trial NCT01218828?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 396 participants. The study started on 2010-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01218828?
The interventions under investigation include: LVEDP -Based hydration strategy (OTHER), Standard hydration (OTHER).
Who is sponsoring clinical trial NCT01218828?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01218828's enrollment target sits among peer trials
396 964th of 2000 higher than 1,036 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- NCT06545331 · 396 participants · Phase 1
Study of XB010 in Subjects With Solid Tumors
- NCT06666790 · 396 participants · NA
DermaSensor Postmarket Surveillance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia